01 6Ozempic
02 5Rybelsus
03 2Wegovy
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 3,450
2019 Revenue in Millions : 1,828
Growth (%) : 89
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 305
2019 Revenue in Millions : 8
Growth (%) : 3,646
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 737
2020 Revenue in Millions : 300
Growth (%) : 158
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 5,137
2020 Revenue in Millions : 3,394
Growth (%) : 59
Main Therapeutic Indication : Nutritional Deficiency
Currency : USD
2022 Revenue in Millions : 902
2021 Revenue in Millions : 211
Growth (%) : 327
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 8,713
2021 Revenue in Millions : 5,137
Growth (%) : 70
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 1,648
2021 Revenue in Millions : 737
Growth (%) : 123
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 2,725
2022 Revenue in Millions : 1,648
Growth (%) : 66
Main Therapeutic Indication : Nutritional Deficiency
Currency : USD
2023 Revenue in Millions : 4,556
2022 Revenue in Millions : 902
Growth (%) : 407
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 13,913
2022 Revenue in Millions : 8,713
Growth (%) : 60
LOOKING FOR A SUPPLIER?
